Health TrialsbyHealthPanel

Home Treatment for Individuals Suffering From Severe Addictive Disorders

ConditionSubstance Use Disorders
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorLouise Penzenstadler

About this trial

Home Treatment (HT) has been successfully implemented in adult psychiatry in several countries including Switzerland. Patients with addiction problems were generally excluded even if the latter was not the main diagnosis. On the other hand, community treatments have successfully been established for these individuals. The investigators have recently offered HT to persons with severe addictive disorders which was well accepted.

The investigators intend to conduct a pilot study to prepare a large-scale study if successful. The investigators intend to compare HT to treatment as usual (regular inpatient treatment) on a specialized ward with respect to readmission rates during 6 months after discharge. The data show that 70.8% of all readmissions occur during the first 6 months. Therefore, a period of 6 months is considered an adequate time interval to sufficiently answer this pilot study's question.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Substance use disorder

age 18 or above

sufficient french language skills

competent subjects

Disqualifiers

organic brain disease or developmental disorder

non voluntary admission

severe somatic comorbidity

History of complicated substance withdrawal

Trial design

Design model

Parallel

Treatments tested in this trial

  • Hospital-like treatment in patients' home

    Other intervention

    Hospital-like treatment in patients' home. Caregivers, medical doctors and social workers will make several visits per day to the patients' home. 24/7 contact is available.

  • standard inpatient treatment

    Other intervention

    Inpatient treatment on addiction ward

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: Home treatmentExperimental treatment 1 intervention
Group B: Standard inpatient treatmentActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

readmission rates

Number of readmissions to hospital during the 6 months following discharge

Time frame
6 month post-discharge

Secondary outcomes

1

time to readmission

Number of days between discharge and readmission during the 6 months following discharge

Time frame
6 months
2

length of hospitalization

total number of days spent in hospital during the 6 months following discharge

Time frame
6 months
3

number of emergency room visits

number of emergency room visits during the 6 months following discharge

Time frame
6 months
4

clinical outcome

clinical outcomes measured with Health of the Nation Outcome scale (HoNOS) scoring 0 (no symptoms) to 48 (high symptom level) and the Brief Symptom Check-List (short form of the Brief Symptom Inventory), scoring 0-53 items (higher score = more symptoms). Measured at the start and end of intervention/hospital treatment.

Time frame
6 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Louise Penzenstadler

Lead sponsor

University Hospital, Geneva

Sponsor institution

Source ClinicalTrials.gov
Apply now